• Home
  • STING contributes to antiglioma immunity via triggering type I IFN signals in the tumor microenvironment.

STING contributes to antiglioma immunity via triggering type I IFN signals in the tumor microenvironment.

Author List
Ohkuri T, Ghosh A, Kosaka A, Zhu J, Ikeura M, David M, Watkins SC, Sarkar SN, Okada H
Publication
Cancer immunology research
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1184202
Publication Year
2014
PubMed ID
25300859
Publication Title
Ohkuri T, Ghosh A, Kosaka A, Zhu J, Ikeura M, David M, Watkins SC, Sarkar SN, Okada H. STING contributes to antiglioma immunity via triggering type I IFN signals in the tumor microenvironment. Cancer Immunol Res. 2014 Dec; 2(12):1199-208.